Pentoxifylline in ischemia-induced acute kidney injury in rats

Renal Failure

Volumn 31, Issue 9, 2009, Pages 829-832

  Okumura, Alice S ^a   Rodrigues, Luiz Erlon ^b   Martinelli, Reinaldo ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

Author keywords

Acute injury; Ischemia; Mitochondria; No protective effect; Pentoxifylline

Indexed keywords

PENTOXIFYLLINE; SODIUM CHLORIDE; SUCCINIC ACID;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; KIDNEY ISCHEMIA; MITOCHONDRIAL RESPIRATION; NEPHRECTOMY; NONHUMAN; POLAROGRAPHY; PRIORITY JOURNAL; RAT; RENAL PROTECTION;

ANIMALS; CELL RESPIRATION; DISEASE MODELS, ANIMAL; FREE RADICAL SCAVENGERS; ISCHEMIA; KIDNEY; MITOCHONDRIA; PENTOXIFYLLINE; RATS; RATS, SPRAGUE-DAWLEY; RENAL INSUFFICIENCY, ACUTE;

EID: 71049124396     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/08860220903137509     Document Type: Article

References (31)

1. Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: Definitions, diagnosis, pathogenesis, and therapy. J Clin Invest. 2004;114:5-14.
2. Block CA, Schoolwerth AC. The epidemiology and outcome of acute renal failure and the impact on chronic kidney disease. Semin Dial. 2006;19:450-454.
3. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39:930-936.
4. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16: 3365-3370.
5. Poggesi L, Scarti L, Boddi M, Masotti G, Serneri GG. Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis. Angiology. 1985;36:628-637.
6. Müller R, Lebrach F. Hemorheological role of platelet aggregation and hypercoagulability in microcirculation: Therapeutical approach with pentoxifylline. Pharmatherapeutica. 1980;2:372-379.
7. Aviado DM, Porter JM. Pentoxifylline: A new drug for the treatment of intermittent claudication. Mechanism of action, pharmacokinetics, clinical efficacy and adverse effects. Pharmacotherapy. 1984;4:297-307.
8. Sullivan GW, Carper HT, Novick WJ Jr, Mandell GL. Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (a) on neutrophil function by pentoxifylline. Infect Immun. 1988;56:1722-1729.
9. Zabel P, Schade FU, Schlaak M. Inhibition of endogenous TNF formation by pentoxifylline. Immunobiology. 1993;187: 447-463.
10. Colson A, Willems B, Thissen JP. Inhibition of TNF-alpha production by pentoxifylline does not prevent endotoxin-induced decrease in serum IGF-I. J Endocrinol. 2003;178:101-109.
11. Ciuffetti G, Mercuri M, Ott C, et al. Use of pentoxifylline as an inhibitor of free radical generation in peripheral vascular disease. Results of a double-blind placebo-controlled study. Eur J Clin Pharmacol. 1991;41:511-515.
12. Wang W, Zolty E, Falk S, Basava V, Reznikov L, Schrier R. Pentoxifylline protects against endotoxin-induced acute renal failure in mice. Am J Physiol Renal Physiol. 2006;291: F1090-F1095.
13. Lin SL, Chen YM, Chien CT, Chiang WC, Tsai CC, Tsai TJ. Pentoxifylline attenuated the renal disease progression in rats with remnant kidney. J Am Soc Nephrol. 2002;13: 2916-2929.
14. Hewitson TD, Martic M, Kelynack KJ, Pedagogos E, Becker GJ. Pentoxifylline reduces in vitro renal myofibroblast proliferation and collagen secretion. Am J Nephrol. 2000;20:82-88.
15. Kowaltowski AJ. Alternative mitochondrial functions in cell physiopathology: Beyond ATP production. Braz J Med Biol Res. 2000;33:241-250.
16. Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev. 2007;87: 99-163. (Pubitemid 46209992)
17. Chan DC. Mitochondria: Dynamic organelles in disease, aging, and development. Cell. 2006;125:1241-1252.
18. Rodrigues LE, Carvalho AA, Azevedo AL, Cruz CB, Maia AW. Odontologic use of copper/aluminum alloys: Mitochondrial respiration as sensitive parameter of biocompatibility. Braz Dent J. 2003;14:32-36.
19. Chen J, Li Y, Lavigne JA, Trush MA, Yager JD. Increased mitochondrial superoxide production in rat liver mitochondria, rat hepatocytes and HepG2 cells following ethinyl estradiol treatment. Toxicol Sci. 1999;51:224-235.
20. de Cavanagh EM, Inserra F, Ferder M, Ferder L. From mitochondria to disease: Role of the renin-angiotensin system. Am J Nephrol. 2007;27:545-553.
21. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol. 2006;17:1503-1520.
22. Jassem W, Heaton ND. The role of mitochondria in ischemia/ reperfusion injury in organ transplantation. Kidney Int. 2004; 66:514-517.
23. Chen J, Li Y, Lavigne JA, Trush MA, Yager JD. Increased mitochondrial superoxide production in rat liver mitochondria, rat hepatocytes and HepG2 cells following ethinyl estradiol treatment. Toxicol Sci. 1999;51:224-235.
24. Komsa-Penkova R, Spirova R, Bechev B. Modification of Lowry's method for collagen concentration measurement. J Biochem Biophys Methods. 1996;32:33-43.
25. Bonventre JV, Zuk A. Ischemic acute renal failure: An inflammatory disease? Kidney Int. 2004;66:480-485.
26. Molitoris BA, Sutton TA. Endothelial injury and dysfunction: Role in the extension phase of acute renal failure. Kidney Int. 2004;66:496-499.
27. Nuydens R, Novalbos J, Dispersyn G, Weber C, Borgers M, Geerts H. A rapid method for evaluation of compounds with mitochondria-protective properties. J Neurosci Methods. 1999;92:153-159.
28. Wystrychowski A, Kokot F, Trzeciak HI. Pentoxifylline (PTX) administered during ischemia and reperfusion ameliorates lipopolysaccharide (LPS) aggravated ischemic acute renal failure (ARF) in rats. Nephrol Dial Transplant. 2002;17 (Suppl. 12):209.
29. Portakal O, Inal-Erden M. Effects of pentoxifylline and coenzyme Q10 in hepatic ischemia-reperfusion injury. Clin Biochem. 1999;32:461-466.
30. Stoiljkovic N, Radenkovic M, Rankovic G, Randjelovic P. Protective effects of pentoxifylline treatment on gentamicininduced nephrotoxicity in rats. Renal Failure. 2009; 31:54-61.
31. Ozer MK, Asci H, Oncu M, Yesilot S, Savran M, Bayram, Cicek E. Effects of pentoxifylline on amikacin-induced nephrotoxicity in rats. Renal Failure. 2009;31:134-135.